Newsletter

Tech Stocks

Test text

Stablecoin Transactions Climb 70% as Rules Loosen

Stablecoins have become one of the most active corners of digital finance, and the latest data showing a 70% jump in payments over a six-month window has pushed the sector back into the spotlight. What stands out this time is not only the pace of growth but the change in how these tokens are being…

ByUjjwal MaheshwariNovember 21, 2025

WiseTech Crashes 50%: Buy the Dip at $67 or Wait?

WiseTech Global (ASX: WTC) has suffered one of the most dramatic falls among ASX tech stocks this year, plunging more than 50% from its November 2024 highs of $141.61 to trade around $67. The sell-off was triggered by governance controversies surrounding founder Richard White, who stepped down as CEO in October 2024 but returned as…

ByUjjwal MaheshwariNovember 21, 2025

Renerve secures A$3.2M to accelerate commercialisation of its nerve repair devices

ReNerve (ASX: RNV) saw a sharp move this month, first surging 66% in a single session to a gain of 70 cents to its share price before pulling back following news of a successful A$3.2M capital raise. The placement was structured across two tranches at A$0.12 per share, representing a 22% discount to the last…

ByCharlie YouldenNovember 20, 2025

Archer Materials Cracks Quantum Readout Challenge as Stock Surges 12%

Archer Materials Just Solved One of Quantum Computing’s Hardest Problems Archer Materials (ASX: AXE) jumped 12% today after unveiling two key developments: successful quantum readout of single electrons and a new quantum machine learning collaboration with CSIRO. The company has now achieved a major milestone in its 12CQ quantum chip roadmap, marking tangible progress toward…

ByCharlie YouldenNovember 20, 2025

NVIDIA’s Blackwell Chips Ignite Record Demand in Q3

NVIDIA’s Blackwell Surge Tech investors and growth-focused funds will be breathing a sigh of relief after NVIDIA (NASDAQ: NVDA) delivered one of its strongest quarters to date, posting record revenue of US$57 billion, up 62% year on year. The standout driver was its data centre division, which reached a record US$51 billion, climbing 66% from…

ByCharlie YouldenNovember 20, 2025

Webjet Surges 17% as Helloworld Tables A$0.90 Cash Offer with 54% Premium

Helloworld’s A$0.90 Cash Bid Sends Webjet Shares Soaring 17% Webjet (ASX: WJL) surged 17% today after Helloworld Travel Limited (ASX: HLO) revealed a non-binding proposal to acquire all remaining shares of Webjet that it does not already own. The offer comes in at A$0.90 per share in cash, and while the structure is still early…

ByCharlie YouldenNovember 19, 2025

TechnologyOne shares drop 18%, but the market may be missing the real story

TechnologyOne shares slide 18 percent, but the cash flow strength tells a very different story TechnologyOne (ASX:TNE) shares fell on Tuesday, though the company delivered another strong year in FY25. The headline performance was solid. Total ARR increased 18% to A$554M and total revenue also grew 18 percent. However, the long term signals introduced a…

ByCharlie YouldenNovember 18, 2025

Metallium Signs Binding 10 Year Deal with New Frontier Minerals After Record Processing Results

Record FJH Results Drive Metallium’s Binding Ten-Year Deal with New Frontier Minerals Metallium (ASX: MTM) delivered a major step forward today with breakthrough Flash Joule Heating results, a binding ten-year exclusive agreement with New Frontier Minerals (ASX: NFM), and a new royalty and commercialisation pathway that positions the company more firmly in the heavy rare…

ByCharlie YouldenNovember 18, 2025

How Mobile Payments Are Redefining Digital Trust in Australia

Mobile payments have become ubiquitous, not just for Aussies, but on a global scale. Google Wallet, Apple Pay, Samsung Pay, and other digital payment apps have taken over, driving the shift from plastic to phone. As convenient as it might be, it showcases a deeper mental shift away from us relying on physical security and…

ByUjjwal MaheshwariNovember 17, 2025

Island Pharmaceuticals Soars 32% After FDA Clears Galidesivir for Animal Rule Pathway

Island Pharmaceuticals Surges 32 Percent on Transformational FDA Decision for Galidesivir Island Pharmaceuticals (ASX: ILA) jumped 32% this morning after announcing that the FDA has agreed to the Animal Rule pathway and has confirmed Priority Review Voucher eligibility for Galidesivir in Marburg. For a company at this stage, these two confirmations meaningfully improve the commercial…

ByCharlie YouldenNovember 17, 2025